NASDAQ:IMPV - Imperva Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$51.85 -0.35 (-0.67 %)
(As of 06/20/2018 03:36 AM ET)
Previous Close$52.20
Today's Range$50.95 - $52.75
52-Week Range$37.17 - $53.95
Volume208,200 shs
Average Volume368,035 shs
Market Capitalization$1.80 billion
P/E Ratio-185.18
Dividend YieldN/A
Beta1.69
Imperva logoImperva, Inc. engages in the development, market, sale, and support of cyber security solutions that protect business critical data and applications in the cloud or on premises worldwide. The company's SecureSphere product line provides database, file, and Web application security in various data centers, including on-premises data centers, as well as in private, public, and hybrid cloud computing environments. Its SecureSphere product also secures business-critical applications and data; and provides an accelerated route to address regulatory compliance and establishes a repeatable process for data risk management. The company's Incapsula service delivers cloud-based Website security, distributed denial of service protection, and load balancing and failover; and is designed to deploy and accessible to businesses that need to optimize the security, speed, and availability of their Websites. Its products also include ThreatRadar that provides reputation and crowdsourced security intelligence services; CounterBreach, which protects enterprise data from theft and loss due to compromised, malicious, and careless users; and Imperva Camouflage Data Masking that creates functional data for development, testing, and training by disguising sensitive information while maintaining the characteristics of the original data. In addition, the company provides ongoing product support services for hardware and software; and professional and training services. Imperva, Inc. offers its products and services to banks, retailers, insurers, technology and telecommunication companies, and hospitals; and the United States and other national, state, and local government agencies through a network of distributors and resellers. The company was founded in 2002 and is headquartered in Redwood Shores, California.

Receive IMPV News and Ratings via Email

Sign-up to receive the latest news and ratings for IMPV and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustrySystems Software
SectorComputer and Technology
SymbolNASDAQ:IMPV
CUSIP45321L10
Phone650-345-9000

Debt

Debt-to-Equity RatioN/A
Current Ratio2.82
Quick Ratio2.82

Price-To-Earnings

Trailing P/E Ratio-185.18
Forward P/E Ratio-85.00
P/E GrowthN/A

Sales & Book Value

Annual Sales$321.72 million
Price / Sales5.59
Cash Flow$0.0559 per share
Price / Cash928.14
Book Value$9.26 per share
Price / Book5.60

Profitability

EPS (Most Recent Fiscal Year)($0.28)
Net Income$22.86 million
Net Margins-3.00%
Return on Equity-1.63%
Return on Assets-0.97%

Miscellaneous

Employees1,020
Outstanding Shares34,690,000

Imperva (NASDAQ:IMPV) Frequently Asked Questions

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva Inc (NASDAQ:IMPV) posted its earnings results on Thursday, April, 26th. The software maker reported $0.26 EPS for the quarter, beating the Zacks' consensus estimate of $0.19 by $0.07. The software maker earned $84.24 million during the quarter, compared to analysts' expectations of $83.77 million. Imperva had a negative net margin of 3.00% and a negative return on equity of 1.63%. Imperva's revenue for the quarter was up 16.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.09 earnings per share. View Imperva's Earnings History.

When is Imperva's next earnings date?

Imperva is scheduled to release their next quarterly earnings announcement on Wednesday, July, 25th 2018. View Earnings Estimates for Imperva.

What price target have analysts set for IMPV?

15 brokerages have issued 1 year price objectives for Imperva's stock. Their forecasts range from $39.00 to $67.00. On average, they anticipate Imperva's stock price to reach $53.4545 in the next year. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:
  • 1. BTIG Research analysts commented, "Imperva posted a strong beat on Non-GAAP EPS, a moderate beat on revenues, and weaker than expected billings, deferred revenues, operating margin and cash flows. Disruptions in the North American salesforce during the quarter seems to have created challenges in delivering the results. While Asia Pacific seems to have been off to a strong start, with Europe following, without the North America engine in full throttle, Imperva cannot get to its destination. We like management’s vision to transform into a hybrid cybersecurity leader, but until we see tangible outcomes, we are forced to remain on the sidelines. Maintain Neutral." (4/29/2018)
  • 2. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (4/11/2018)

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:
  • Ms. Trâm T. Phi, Sr. VP, Gen. Counsel & Corp. Sec. (Age 47)
  • Mr. Christopher S. Hylen, Pres, CEO & Director (Age 57)
  • Mr. Michael J. Burns, Chief Financial Officer & Treasurer (Age 52)
  • Mr. Aharon Strosberg, VP of Operations
  • Mr. Terry Ray, Chief Technology Officer

Has Imperva been receiving favorable news coverage?

Media coverage about IMPV stock has been trending somewhat negative recently, Accern Sentiment Analysis reports. Accern identifies positive and negative press coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Imperva earned a media sentiment score of -0.02 on Accern's scale. They also gave news stories about the software maker an impact score of 40.10 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

Who are Imperva's major shareholders?

Imperva's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.52%), Eagle Asset Management Inc. (3.82%), ETF Managers Group LLC (3.31%), Millennium Management LLC (2.10%), Rothschild Asset Management Inc. (1.44%) and Northern Trust Corp (1.19%). Company insiders that own Imperva stock include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev and Terrence J Schmid. View Institutional Ownership Trends for Imperva.

Which major investors are selling Imperva stock?

IMPV stock was sold by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., North Run Capital LP, ETF Managers Group LLC, Millennium Management LLC, Wells Fargo & Company MN, Smith Asset Management Group LP and Point72 Asset Management L.P.. Company insiders that have sold Imperva company stock in the last year include Anthony J Bettencourt and Michael D Mooney. View Insider Buying and Selling for Imperva.

Which major investors are buying Imperva stock?

IMPV stock was acquired by a variety of institutional investors in the last quarter, including Legal & General Group Plc, Impax Asset Management LLC, Hsbc Holdings PLC, Highbridge Capital Management LLC, Segall Bryant & Hamill LLC, Broadview Advisors LLC, Roystone Capital Management LP and Prudential Financial Inc.. View Insider Buying and Selling for Imperva.

How do I buy shares of Imperva?

Shares of IMPV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of IMPV stock can currently be purchased for approximately $51.85.

How big of a company is Imperva?

Imperva has a market capitalization of $1.80 billion and generates $321.72 million in revenue each year. The software maker earns $22.86 million in net income (profit) each year or ($0.28) on an earnings per share basis. Imperva employs 1,020 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]


MarketBeat Community Rating for Imperva (IMPV)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  588 (Vote Outperform)
Underperform Votes:  309 (Vote Underperform)
Total Votes:  897
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe IMPV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IMPV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/20/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.